New diabetes drug combo tested for safety in 2,000 patients
NCT ID NCT05164263
First seen Jan 31, 2026 · Last updated May 26, 2026 · Updated 9 times
Summary
This study is checking how safe and well-tolerated empagliflozin (a diabetes medicine) is when taken with or without metformin. It involves about 2,000 adults with type 2 diabetes in Pakistan who are not well-controlled on their current treatment. Participants will be followed for 6 months to track side effects and blood sugar changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY ISSUES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Agha Khan univeristy hospital
RECRUITINGNairobi, Kenya, Kenya
Contact
-
Kabul University of Medical Sciences(KUMS)
COMPLETEDKabul, Afghanistan, Afghanistan
-
Lagos University Teaching Hospital
RECRUITINGLagos, Nigeria, Nigeria
Contact
Contact
Contact
-
NHK
COMPLETEDKandy, Kandy, Sri Lanka
-
National hospital Sri Lanka
COMPLETEDColombo, Colombo, Sri Lanka
-
Umar Diabetes Foundation
COMPLETEDIslamabad, Pakistan
Conditions
Explore the condition pages connected to this study.